Select for export Longitudinal experiences of Canadians receiving compassionate access to psilocybin-assisted psychotherapy Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41598-024-66817-0 PubMed 39019922 Copy citation Copy BibTeX Scientific Reports 2024-07-16 Sara de la Salle, Hannes Kettner, Julien Thibault Lévesque, Nicolas Garel, Shannon Dames, Ryan Patchett-Marble OpenAlex Published psilocybin DepressionAnxietyEnd-of-Life Distress Clinical Trial More
Select for export Serotoninergic antidepressants combination in psilocybin-assisted psychotherapy: a case report Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2024.1394962 PubMed 39086732 Copy citation Copy BibTeX Frontiers in Psychiatry 2024-07-15 André Do, Vanessa Michaud, Jean-François Stephan, Miltiadis Moreau, Élise Benoît, Felix-Antoine Berubé OpenAlex Published psilocybin DepressionAnxietyHeadache / Migraine Clinical Trial More
Select for export Psilocybin for the treatment of Alzheimer's disease. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fnins.2024.1420601 PubMed 39050672 Copy citation Copy BibTeX Unknown journal 2024-07-09 Zheng S, Ma R, Yang Y, Li G. Europe PMC Published psilocybinpsilocin DepressionAnxietyNeuroplasticity Review Article More
Select for export Psilocybin in the Management of Substance Use Disorders: A Summary ofCurrent Evidence Abstract available at the source but not redistributed here. Read at source. Details DOI 10.2174/0122115560288779240628043307 Copy citation Copy BibTeX Current Psychopharmacologye 2024-07-03 Hussein El Bourji, Aziz Farhat, Zahi Hamdan, Ritvij Satodiya, Rashmi Shukla, Samer El Hayek OpenAlex Published psilocybin DepressionAnxietyAddiction Randomized Controlled Trial More
Select for export Addressing a major interference in the quantification of psilocin in mouse plasma: Development of a validated liquid chromatography tandem mass spectrometry method Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.chroma.2024.465123 PubMed 38981146 Copy citation Copy BibTeX Journal of Chromatography A 2024-07-03 Amir Khajavinia, Déborah Michel, Udoka C. Ezeaka, Randy W. Purves, Robert B. Laprairie, Anas El-Aneed OpenAlex Published psilocybinpsilocin DepressionAnxietyPTSD Clinical Trial More
Select for export Engaging Mood Brain Circuits with Psilocybin (EMBRACE): a study protocol for a randomized, placebo-controlled and delayed-start, neuroimaging trial in depression Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1186/s13063-024-08268-6 PubMed 38956594 Copy citation Copy BibTeX Trials 2024-07-02 Joshua M. Poulin, Gregory E. Bigford, Krista L. Lanctôt, Peter Giacobbe, Ayal Schaffer, Mark Sinyor OpenAlex Published psilocybin DepressionAnxietyChronic Pain Randomized Controlled Trial More
Select for export Treating Anxiety and Depression With Psilocybin Therapy. No abstract availability was recorded for this entry. Details PubMed 39079732 Copy citation Copy BibTeX PubMed 2024-06-30 Amanda Paige Hanstein, Chance Felchlin OpenAlex Published psilocybin DepressionAnxiety Other More
Select for export Investigating the therapeutic efficacy of psilocybin in advanced cancer patients: A comprehensive review and meta-analysis. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.5306/wjco.v15.i7.908 PubMed 39071471 Copy citation Copy BibTeX Unknown journal 2024-06-30 Bader H, Farraj H, Maghnam J, Abu Omar Y. Europe PMC Published psilocybin DepressionAnxietyChronic Pain Meta-Analysis More
Select for export IS PSYCHEDELIC TREATMENT OF MENTAL HEALTH DISORDERS READY FOR PRIME TIME? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.63050/jpps.21.02.935 Copy citation Copy BibTeX Journal of Pakistan Psychiatric Society 2024-06-29 Nauman Ashraf OpenAlex Published psilocybin DepressionAnxietyPTSD Other More
Select for export Developing the Open Psychedelic Evaluation Nexus consensus measures for assessment of supervised psilocybin services: An e-Delphi study Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811241257839 PubMed 38888164 Copy citation Copy BibTeX Journal of Psychopharmacology 2024-06-17 P. Todd Korthuis, Kim Hoffman, Adrianne R. Wilson-Poe, Jason B. Luoma, Alissa Bazinet, Kellie Pertl OpenAlex Published psilocybin DepressionAnxietyWellbeing Clinical Trial More
Select for export Licit use of illicit drugs for treating depression: the pill and the process. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1172/jci180217 PubMed 40047885 Copy citation Copy BibTeX Unknown journal 2024-06-16 Torrado Pacheco A, Moghaddam B. Europe PMC Published psilocybin DepressionAnxietyPTSD Clinical Trial More
Select for export A Multi-centre, Double-blinded, Placebo-controlled, Randomised, Phase II Clinical Trial for Psilocybin-assisted Therapy for Alcohol Use Disorder Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2024-06-09 University of Sydney ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionAnxietyAddiction Randomized Controlled Trial More
Select for export Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin Receptor Abstract available at the source but not redistributed here. Read at source. Details DOI 10.17615/yb2v-ca64 Copy citation Copy BibTeX UNC Libraries 2024-06-06 Ouliana Panova, Nichols D.E, Shoichet B.K, Lyu J, Georgios Skiniotis, Che T OpenAlex Published psilocybinpsilocin DepressionAnxietyPharmacology Other More
Select for export Effect of oral tryptamines on the gut microbiome of rats-a preliminary study Abstract available at the source but not redistributed here. Read at source. Details DOI 10.7717/peerj.17517 PubMed 38846751 Copy citation Copy BibTeX PeerJ 2024-06-02 Mengyang Xu, Andor J. Kiss, J. Andrew Jones, Matthew S. McMurray, Haifei Shi OpenAlex Published psilocybin DepressionAnxietyPharmacology Other More
Select for export On serotonin, psychedelics, entactogens and psychoplastogens in depression, anxiety, post-traumatic stress, and related disorders. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.22541/au.171648613.31141136/v1 Copy citation Copy BibTeX Authorea Preprints 2024-05-22 Hoyer D. Europe PMC PREPRINT (not peer reviewed) psilocybin DepressionAnxietyPTSD Clinical Trial More
Select for export Psychedelic therapy in depression and substance use disorders. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1111/ejn.16421 PubMed 38773750 Copy citation Copy BibTeX Unknown journal 2024-05-20 Korkmaz ND, Cikrikcili U, Akan M, Yucesan E. Europe PMC Published psilocybin DepressionAnxietyAddiction Other More
Select for export A Case Report of Psilocybin-induced Psychosis in a Predisposed Patient Abstract available at the source but not redistributed here. Read at source. Details DOI 10.9758/cpn.24.1180 PubMed 39420616 Copy citation Copy BibTeX Clinical Psychopharmacology and Neuroscience 2024-05-20 S Morris OpenAlex Published psilocybin DepressionAnxietyPersonality Change Review Article More
Select for export Psychedelic renaissance: A renewed focus on the clinical utility of hallucinogens Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/pcn5.196 Copy citation Copy BibTeX Psychiatry and Clinical Neurosciences Reports 2024-05-15 Shunichiro Ikeda, Toshihiko Kinoshita OpenAlex Published psilocybin DepressionAnxietyPTSD Clinical Trial More
Select for export Psilocybin as a new way for depression treatment Abstract available at the source but not redistributed here. Read at source. Details DOI 10.12775/jehs.2024.68.50168 Copy citation Copy BibTeX Journal of Education Health and Sport 2024-05-14 Mateusz Pawlicki, Aleksandra Kłos, Karol Stachyrak, Dawid Mika, Bartosz Mazur, Kamila Turek OpenAlex Published psilocybin DepressionAnxietyEnd-of-Life Distress Other More
Select for export An Open-Label Investigation of the Effects of Sub-Perceptual Repeat Dosing of Psilocybin on the Behavioural and Cognitive Symptoms of Fragile X Syndrome in Adult Patients Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2024-05-07 Nova Mentis Life Science Corp ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionAnxietyNeuroplasticity Review Article More
